- Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study GroupK Ewe
I Medizinische Klinik und Poliklinik, Johannes Gutenberg Universitat Mainz, Germany
Eur J Gastroenterol Hepatol 11:277-82. 1999..Endoscopic recurrence of Crohn's disease frequently occurs within weeks after 'curative' operation. Treatment with 3 x 1 mg oral pH-modified release budesonide was tried to prevent postoperative recurrence...